Benefits
DashboardNot registered yet? Get a free account.
Sign Up
SKANDANANA PHARMA PRIVATE LIMITED
Leave site?
You're about to leave our website and go to an external link. Are you sure?
Skandanana Pharma Private Limited, is an unlisted private company incorporated on 01 April, 2020. It is classified as a private limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 10.00 lac and the total paid-up capital is INR 1.00 lac.
The current status of Skandanana Pharma Private Limited is - Active.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.9%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Dashboards
Popular Plan-
₹ 449
Company dashboard-
Five year financials and ratios
-
Risk analysis
-
Interactive charts
-
Buy credits
View subscriptions
MCA Fillings
-
₹ 249
1 Year
-
Latest financials
-
Latest annual return
-
MoA and AoA
-
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
₹ 449 + GST
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
Locations
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Select Tags
Choose Location
People
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Nagendra Kumar Vallamkonda | 06742154 | 5 years |
| Director | Vallamkonda Lakshmi Sravani | 08732040 | 5 years |
Financial Highlights
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Margins
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets
Charges on assets
ICICI Bank Limited
No. of Loans: 1
Total Amount : 2.0 cr
Charges
Company Network
Expand
Delete
Collapse
See
details
Companies connected through Directors
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SANSEC PHARMA SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| SPCAL LABS PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
| SKANDANAN INFRA PROJECTS PRIVATE LIMITED |
Not available for efiling
|
10.0 L | 2 | Telangana |
| SKANDANA LIFE SCIENCES LLP |
Inactive for e-filing
|
5.0 L | 1 | Telangana |
Tofler Score
Risk
Severe Risk
- No risks identified
Moderate Risk
- No risks identified
Low Risk
- No risks identified
About Tofler Score
Read more
Registered Details
CIN
U93000TG2020PTC140032PAN
-Incorporation
2020, 5.3 yearsCompany Email
nagendra@spcalibrationlabs.comPaid up Capital
₹ 1.0 LAuthorised Capital
₹ 10.0 LAGM
Sep 2023Type
FAQ - SKANDANANA PHARMA PRIVATE LIMITED
What is the incorporation date of SKANDANANA PHARMA PRIVATE LIMITED?
The incorporation date of SKANDANANA PHARMA PRIVATE LIMITED is 01 April, 2020
What is the authorized share capital of SKANDANANA PHARMA PRIVATE LIMITED?
The authorized share capital of SKANDANANA PHARMA PRIVATE LIMITED is INR ₹ 10.0 L.
What is the paid-up capital of SKANDANANA PHARMA PRIVATE LIMITED?
The paid-up capital of SKANDANANA PHARMA PRIVATE LIMITED is INR ₹ 1.0 L.
What is the registered address of SKANDANANA PHARMA PRIVATE LIMITED?
The registered address of SKANDANANA PHARMA PRIVATE LIMITED is PLOT NO.46&47,2ND FLOOR,SURVEY NO.152,153&154,155 BLOCKNO.167,PRAGATHINAGAR,BACHPALLY,MALKAJGIRI HYDERABAD Hyderabad Telangana - 500090
What is the CIN number of SKANDANANA PHARMA PRIVATE LIMITED?
The CIN number of SKANDANANA PHARMA PRIVATE LIMITED is U93000TG2020PTC140032.
